These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30515997)

  • 21. Multi-country analysis of treatment costs for HIV/AIDS (MATCH): facility-level ART unit cost analysis in Ethiopia, Malawi, Rwanda, South Africa and Zambia.
    Tagar E; Sundaram M; Condliffe K; Matatiyo B; Chimbwandira F; Chilima B; Mwanamanga R; Moyo C; Chitah BM; Nyemazi JP; Assefa Y; Pillay Y; Mayer S; Shear L; Dain M; Hurley R; Kumar R; McCarthy T; Batra P; Gwinnell D; Diamond S; Over M
    PLoS One; 2014; 9(11):e108304. PubMed ID: 25389777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A protocol for feasibility of plasma based GeneXpert platform and Dried Blood Spot (DBS) based Abbott platform for HIV-1 viral load testing among the people living with HIV attending ART centers in India.
    Kamble S; Shidhaye P; Mukherjee A; Tak M; Bembalkar S; Aggarwal S; Deb A; Kapoor N; Verma V; Das C; Kulkarni S; Ghate M; Godbole S
    PLoS One; 2023; 18(5):e0285942. PubMed ID: 37200292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study.
    Kahn JG; Marseille E; Moore D; Bunnell R; Were W; Degerman R; Tappero JW; Ekwaru P; Kaharuza F; Mermin J
    BMJ; 2011 Nov; 343():d6884. PubMed ID: 22074713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-uptake of viral load testing among people receiving HIV treatment in Gomba district, rural Uganda.
    Nakalega R; Mukiza N; Kiwanuka G; Makanga-Kakumba R; Menge R; Kataike H; Maena J; Akello C; Atuhaire P; Matovu-Kiweewa F; Ndikuno-Kuteesa C; Debem H; Mujugira A
    BMC Infect Dis; 2020 Oct; 20(1):727. PubMed ID: 33023498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viral load testing and the use of test results for clinical decision making for HIV treatment in Cameroon: An insight into the clinic-laboratory interface.
    Awungafac G; Amin ET; Fualefac A; Takah NF; Agyingi LA; Nwobegahay J; Ondoa P; Njukeng PA
    PLoS One; 2018; 13(6):e0198686. PubMed ID: 29889862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Routine viral load monitoring in HIV-infected infants and children in low- and middle-income countries: challenges and opportunities.
    Arpadi SM; Shiau S; De Gusmao EP; Violari A
    J Int AIDS Soc; 2017 Nov; 20 Suppl 7(Suppl 7):. PubMed ID: 29171190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settings.
    Schneider K; Puthanakit T; Kerr S; Law MG; Cooper DA; Donovan B; Phanuphak N; Sirisanthana V; Ananworanich J; Ohata J; Wilson DP
    AIDS; 2011 Jun; 25(9):1143-51. PubMed ID: 21505319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation and Operational Research: Risk Charts to Guide Targeted HIV-1 Viral Load Monitoring of ART: Development and Validation in Patients From Resource-Limited Settings.
    Koller M; Fatti G; Chi BH; Keiser O; Hoffmann CJ; Wood R; Prozesky H; Stinson K; Giddy J; Mutevedzi P; Fox MP; Law M; Boulle A; Egger M
    J Acquir Immune Defic Syndr; 2015 Nov; 70(3):e110-9. PubMed ID: 26470034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laboratory Monitoring of Antiretroviral Therapy for HIV Infection: Cost-Effectiveness and Budget Impact of Current and Novel Strategies.
    Ouattara EN; Robine M; Eholié SP; MacLean RL; Moh R; Losina E; Gabillard D; Paltiel AD; Danel C; Walensky RP; Anglaret X; Freedberg KA
    Clin Infect Dis; 2016 Jun; 62(11):1454-1462. PubMed ID: 26936666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics.
    Koethe JR; Westfall AO; Luhanga DK; Clark GM; Goldman JD; Mulenga PL; Cantrell RA; Chi BH; Zulu I; Saag MS; Stringer JS
    PLoS One; 2010 Mar; 5(3):e9680. PubMed ID: 20300631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reflecting the real value of health care resources in modelling and cost-effectiveness studies-The example of viral load informed differentiated care.
    Revill P; Walker S; Cambiano V; Phillips A; Sculpher MJ
    PLoS One; 2018; 13(1):e0190283. PubMed ID: 29293611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries.
    Raboud JM; Loutfy MR; Su D; Bayoumi AM; Klein MB; Cooper C; Machouf N; Rourke S; Walmsley S; Rachlis A; Harrigan PR; Smieja M; Tsoukas C; Montaner JS; Hogg RS;
    BMC Infect Dis; 2010 Feb; 10():40. PubMed ID: 20184766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV treatment and monitoring patterns in routine practice: a multi-country retrospective chart review of patient care.
    Musa BM; Ibekwe E; Mwale S; Eurien D; Oldenburg C; Chung G; Heller RF
    F1000Res; 2018; 7():713. PubMed ID: 30647906
    [No Abstract]   [Full Text] [Related]  

  • 34. On the front line of HIV virological monitoring: barriers and facilitators from a provider perspective in resource-limited settings.
    Rutstein SE; Golin CE; Wheeler SB; Kamwendo D; Hosseinipour MC; Weinberger M; Miller WC; Biddle AK; Soko A; Mkandawire M; Mwenda R; Sarr A; Gupta S; Mataya R
    AIDS Care; 2016; 28(1):1-10. PubMed ID: 26278724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Evaluation of an Affordable Qualitative Viral Failure Assay for HIV Using Dried Blood Spots in Uganda.
    Balinda SN; Ondoa P; Obuku EA; Kliphuis A; Egau I; Bronze M; Kasambula L; Schuurman R; Spieker N; Rinke de Wit TF; Kityo C;
    PLoS One; 2016; 11(1):e0145110. PubMed ID: 26824465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The integration of tuberculosis and HIV testing on GeneXpert can substantially improve access and same-day diagnosis and benefit tuberculosis programmes: A diagnostic network optimization analysis in Zambia.
    Girdwood S; Pandey M; Machila T; Warrier R; Gautam J; Mukumbwa-Mwenechanya M; Benade M; Nichols K; Shibemba L; Mwewa J; Mzyece J; Lungu P; Albert H; Nichols B; Choonga P
    PLOS Glob Public Health; 2023; 3(1):e0001179. PubMed ID: 36963019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Optimizing resources to reduce costs to determine HIV viral load in limited resources settings].
    Girón-Callejas A; Mendizabal-Burastero R; Yax E; Martínez A; Mejía-Villatoro C
    Biomedica; 2017 Dec; 37(4):460-465. PubMed ID: 29373766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomes.
    Bardon AR; Dorward J; Sookrajh Y; Sayed F; Quame-Amaglo J; Pillay C; Feutz E; Ngobese H; Simoni JM; Sharma M; Cressey TR; Gandhi M; Lessells R; Moodley P; Naicker N; Naidoo K; Thomas K; Celum C; Abdool Karim S; Garrett N; Drain PK
    BMJ Open; 2021 Oct; 11(10):e050116. PubMed ID: 34610939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Point-of-care viral load monitoring: outcomes from a decentralized HIV programme in Malawi.
    Nicholas S; Poulet E; Wolters L; Wapling J; Rakesh A; Amoros I; Szumilin E; Gueguen M; Schramm B
    J Int AIDS Soc; 2019 Aug; 22(8):e25387. PubMed ID: 31441242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-financing for viral load monitoring during the course of antiretroviral therapy among patients with HIV/AIDS in Vietnam: A contingent valuation survey.
    Nguyen QL; Nguyen LH; Tran BX; Phan HT; Le HT; Nguyen HD; Tran TD; Do CD; Nguyen CM; Thuc VT; Latkin C; Zhang MW; Ho RC
    PLoS One; 2017; 12(2):e0172050. PubMed ID: 28199405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.